Tufts CSDD Outlook

Tufts CSDD’s Outlook, published each January, highlights near-term pharmaceutical and biopharmaceutical development trends. Data and analyses contained in Tufts CSDD’s Outlook are based on proprietary research conducted by the Tufts CSDD staff, and include insights into current industry, regulatory, and policy trends. Tufts CSDD's Outlook is complimentary to Tufts CSDD Impact Report subscribers.

Here are the highlights of Tufts CSDD's Outlook 2014

R&D Trends: While drug sponsors have taken numerous steps during the last decade to increase R&D productivity, investors, payers, and other stakeholders are pushing for further improvements, which will boost bioinnovation.

Regulatory Environment: Regulatory authorities in the U.S. and Europe will become more proactive, working in a quasi-partnership manner with drug sponsors to increase the pace of new product development while stepping up vigilance over patient safety.

Biotechnology Sector Trends: Continued development of new technology platforms will foster a growing cornucopia of biotech products, which, in turn, will reinforce Big Pharma interest and investment in large molecule product development.

Prescription Drug Policy: Rising prescription drug costs and growing use of drug therapies by an expanding patient population worldwide will lead payers to impose stricter reimbursement regimes.

R&D Management and Operations: Drug developers will deploy strategies to optimize study design, collaborative relationships, and patient engagement in clinical research to drive higher levels of operating performance at lower cost.

To get a free copy of the Tufts CSDD Outlook 2014, send us an email with the words "Outlook 2014 request" in the subject heading.

PLEASE NOTE: Orders are processed as quickly as possible during Tufts CSDD business hours, Monday-Friday, 9AM – 5PM (excluding unversity holidays). Orders placed outside of business hours or on weekends will be processed and delivered at the on the following business day.


Press Releases